Tradipitant: meta-analysis of COVID-19 studies

Meta-analysis1 study · 145 patientsc19early.org

Tradipitant for COVID-19

Serious outcome risk
Tradipitant
Control
Outcome (studies)
Improvement
Relative risk · 95% CI
All studies (1)−36%
Mortality (1)−36%
RCTs (1)−36%
Late (1)−36%
00.511.5+
← Tradipitant
reduces risk
Increased
risk →
October 2026

Tradipitant COVID-19 studies

StudyImprovementRR · 95% CIOutcomeTreatmentControlRelative Risk
Late treatment−36%1.36 · 0.70–2.6116/6913/7636% higher risk
Tau² = 0.00, I² = 0.0%, p = 0.37
All studies−36%1.36 · 0.70–2.6116/6913/7636% higher risk
Tau² = 0.00, I² = 0.0%, p = 0.3700.511.52+
Rotate screen for more detailsIncrease width for more details
← Tradipitant
reduces risk
Tradipitant
increases risk →
October 2026

Tradipitant COVID-19 mortality results

StudyImprovementRR · 95% CITreatmentControlRelative Risk
Late treatment−36%1.36 · 0.70–2.6116/6913/7636% higher risk
Tau² = 0.00, I² = 0.0%, p = 0.37
All studies−36%1.36 · 0.70–2.6116/6913/7636% higher risk
Tau² = 0.00, I² = 0.0%, p = 0.3700.511.52+
Rotate screen for more detailsIncrease width for more details
← Tradipitant
reduces risk
Tradipitant
increases risk →
October 2026

Tradipitant COVID-19 serious outcomes

StudyImprovementRR · 95% CIOutcomeTreatmentControlRelative Risk
Late treatment−36%1.36 · 0.70–2.6116/6913/7636% higher risk
Tau² = 0.00, I² = 0.0%, p = 0.37
All studies−36%1.36 · 0.70–2.6116/6913/7636% higher risk
Tau² = 0.00, I² = 0.0%, p = 0.3700.511.52+
Rotate screen for more detailsIncrease width for more details
← Tradipitant
reduces risk
Tradipitant
increases risk →
October 2026

Tradipitant COVID-19 Randomized Controlled Trials

StudyImprovementRR · 95% CIOutcomeTreatmentControlRelative Risk
Late treatment−36%1.36 · 0.70–2.6116/6913/7636% higher risk
Tau² = 0.00, I² = 0.0%, p = 0.37
All studies−36%1.36 · 0.70–2.6116/6913/7636% higher risk
Tau² = 0.00, I² = 0.0%, p = 0.3700.511.52+
Rotate screen for more detailsIncrease width for more details
← Tradipitant
reduces risk
Tradipitant
increases risk →
October 2026

Tradipitant COVID-19 RCT mortality results

StudyImprovementRR · 95% CITreatmentControlRelative Risk
Late treatment−36%1.36 · 0.70–2.6116/6913/7636% higher risk
Tau² = 0.00, I² = 0.0%, p = 0.37
All studies−36%1.36 · 0.70–2.6116/6913/7636% higher risk
Tau² = 0.00, I² = 0.0%, p = 0.3700.511.52+
Rotate screen for more detailsIncrease width for more details
← Tradipitant
reduces risk
Tradipitant
increases risk →